Status:

COMPLETED

Loxapine and Weaning From Ventilator

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Respiratory Insufficiency

Psychomotor Agitation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Patients may be very agitated during the weaning period from mechanical ventilation. Administration of loxapine, a neuroleptic that does not notably affect ventilatory drive, may help in obtaining an ...

Detailed Description

Mechanical ventilation is a life-saving procedure in critically ill patients. This procedure is however not devoid of risks and every effort should be made to shorten its duration. This is best accomp...

Eligibility Criteria

Inclusion

  • Patients who are eligible for weaning from the respirator (FIO2 less than 50%; positive end expiratory pressure \[PEEP\] level less than 6 cmH2O)
  • Patients whose agitation (according to accepted scores) during a weaning trial precludes extubation

Exclusion

  • History of convulsions or epilepsy

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2006

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT00122733

Start Date

December 1 2005

End Date

December 1 2006

Last Update

July 23 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service de Réanimation, Hopital Louis Mourier

Colombes, France, 92700